Clinical value of dynamic testing of viral load level in blood at patients with natural course of chronic HBV-monoinfection
Abstract
Aim of investigation. To determine clinical value of viral load level (VLL) of HBV in blood at patients with natural course of chronic HBV-monoinfection.
Material and methods. Overall 149 patients were investigated. Of them 68 (45,6%) were women and 81 man (54,4%) in the age of 16 to 71 years. Molecularbiological analysis for the presence of hepatitis B virus DNA in blood was carried out three times with 6 months intervals by polymerase chain reaction (PCR) method in a «real time» mode (test-sensitivity 103 copies/ml).
Results. At triple complex investigation 20% of HBsAg inactive carriers have been selected. At a single PCR – test at the majority (59,5%) of patients with chronic hepatitis B (CHB) no HBV DNA was determined in a blood, while at two-times and triple study the number of patients with not determined HBV DNA level reduced apparently (41 and 12,5% respectively). Analysis has indicated, that CHB patients have direct correlation between alanine transaminases (ALT) activity and HBV DNA VLL (r=0,385, р=0,008). Only in 9% of cases constantly high VLL was registered, mainly, on a background of elevated activity of ALT. The progressing form of CHB has been diagnosed in 21,7% of patients with natural course of chronic HBV-monoinfection for this they have been recognized as candidates for antiviral therapy.
Conclusions. In original study the direct correlation between parameters of HBV VLL and ALT activity at patients with natural course of chronic HBV-monoinfection was revealed. Only complex dynamic assessment of such patients helps to define absolute candidates for prescription of antiviral therapy and to determine proportion of inactive HBsAg carriers.
About the Authors
S. A. ShutkoRussian Federation
K. R. Dudina
Russian Federation
O. O. Znoyko
Russian Federation
Ye. A. Klimova
Russian Federation
V. I. Kashirin
Russian Federation
D. S. Cheshik
Russian Federation
N. D. Yushchuk
Russian Federation
References
1. Agalar C., Diri C., Ucubutum S. The role of HBV DNA and liver histopathology in HBsAg carriers // Hepatogastroenterology. – 1997. – Vol. 44, N 16. – P. 1196–1199.
2. Chen C.J., Yang H.I., Su J. et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load // Gastroenterology. – 2006. – Vol. 130, N 3. – P. 678–686.
3. Chen C.J., Yang H.I., Su J. et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level // JAMA. – 2006. – Vol. 295, N 1. – P. 65–73.
4. Emmet B., Douglas T. A treatment algorithm for the management of chronic HBV infection in the U.S. // Clin. Gastroenterol. Hepatol. – 2004. – Vol. 2, N2. – P. 87–106.
Review
For citations:
Shutko S.A., Dudina K.R., Znoyko O.O., Klimova Ye.A., Kashirin V.I., Cheshik D.S., Yushchuk N.D. Clinical value of dynamic testing of viral load level in blood at patients with natural course of chronic HBV-monoinfection. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2009;19(6):28-33. (In Russ.)
Views:
27
Email this article 
